MIF Facilitates Resistance to Androgen Deprivation Therapy by Regulating AMPD2 Expression in Prostate Cancer Cells

Researchers demonstrated that androgen deprivation therapy (ADT) induces macrophage migration inhibitory factor (MIF) upregulation, which in turn drives prostate cancer cell proliferation via upregulating AMPD2 expression, eventually contributing to the development of resistance to ADT.